Akèy › Metiyè › Biochemists and Biophysicists › Rockville, MD
Biochemists and Biophysicists nan Rockville, MD: Salè H-1B
41 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Rockville, MD. Salè baz medyàn ofri $81,500; mwatye mitan $76,963–$109,128.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $78,000 |
| Nivo II (kalifye) | $111,008 |
| Nivo III (eksperyans) | $131,955 |
| Nivo IV (plen kompetans) | $124,922 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| National Institutes of Health, HHS | 9 | $96,250 |
| Hansoh Bio LLC | 7 | $109,354 |
| University of Maryland College Park | 6 | $66,243 |
| Corixa Corporation | 2 | $100,411 |
| AbVacc Inc. | 2 | $113,000 |
| Fina Biosolutions LLC | 1 | $76,960 |
| University of Maryland | 1 | $61,469 |
| mProbe, Inc. | 1 | $77,000 |
| MacroGenics, Inc. | 1 | $74,610 |
| TopAlliance Biosciences, Inc. | 1 | $80,000 |
| HitGen Pharmaceuticals Inc | 1 | — |
| TopAllicance Biosciences, Inc. | 1 | $80,000 |
| BioReliance Corporation | 1 | $82,000 |
| Kaigene, Inc | 1 | $67,038 |
| Dexorgen, Inc. | 1 | — |
| Innovative Cellular Therapeutics, Inc. | 1 | $80,000 |
| Arcellx, Inc. | 1 | — |
| Cedars-Sinai Medical Center | 1 | $71,094 |
| GAP Solutions Inc. | 1 | $145,000 |
| Axle Informatics LLC | 1 | $200,000 |
Tit travay
- Research Fellow8
- Assistant Research Scientist6
- Scientist3
- Research Scientist2
- Assistant Director, Assay Development & Qualification2
- Biochemist2
- Biochemists2
- Senior Scientist2
- Conjugation Scientist1
- Expert Scientist1
- Pharmaceutical Development Associate1
- Staff Scientist1
- Scientist, Protein Purification and Analytics1
- Report Writer II1
- Post-Doctoral Associate1
Pwonse H-1B nan Rockville, MD →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).